111

111 Debt/EBITDA

The Total Debt to EBITDA Ratio of 111 (YI) as of Nov 2, 2026 is -21.71. In the previous year, Total Debt to EBITDA Ratio was 121.46 — a change of -117.88% (lower).

Debt/EBITDA

-21.71

YoY

-117.88%

Last updated:

Total Debt to EBITDA Ratio of 111 is 2025 -21.71 . Total Debt to EBITDA Ratio of 111 was 2024 121.46 . It decreases by -117.88% lower compared to the previous year.

The 111 Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2018
-0.01 CNY
Jan 1, 2019
-0.42 CNY
Jan 1, 2020
-0.70 CNY
Jan 1, 2021
-0.76 CNY
Jan 1, 2022
-0.95 CNY
Jan 1, 2023
-1.33 CNY
Jan 1, 2024
121.46 CNY
Jan 1, 2025
-21.71 CNY
The 111 Debt/EBITDA history
YEARDebt/EBITDAYoY
-21.71-117.88%
121.46-9,226.60%
-1.33+40.21%
-0.95+24.13%
-0.76+9.89%
-0.70+64.50%
-0.42+6,767.88%
-0.01-96.39%
-0.17+22.79%
-0.14—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

111 Stock analysis

What does 111 do? 111 Inc, trading under the ticker YI and ISIN US68247Q2012, is a company based in Shanghai, China, operating within the Consumer Staples sector and Retail industry. The company went public on September 12, 2018. According to the provided information, 111 Inc is engaged in the provision of pharmaceutical products and medical services through online retail pharmacy and an indirect offline pharmacy network. The company's website is http://gangling.111.com.cn/. The employee count provided in the user message is 144, though the source description mentions 1,932 full-time employees, which is inconsistent. The company focuses on online medical services, drug purchasing, and health management services utilizing internet and information technology. It primarily serves the domestic market in China. The company's headquarters are located in Shanghai, Shanghai, and it operates with a focus on retail and consumer staples within the pharmaceutical and healthcare services domain. 111 is one of the most popular companies on Eulerpool.

Frequently Asked Questions about 111 stock

Total Debt to EBITDA Ratio of 111 is -21.71 in 2025.

Total Debt to EBITDA Ratio of 111 changed from 121.46 to -21.71, representing a -117.88% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio 111 since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's 111 with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — 111

All Key Metrics — 111